OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
872958

8729.T

Life & Health InsuranceVerified

The company maintains a capital structure with a debt-to-equity ratio of 7.29, indicating a significant reliance on debt financing relative to equity. Its liquidity position is characterized by cash and equivalents of ¥1.22 trillion, but this is offset by long-term debt of ¥4.88 trillion, resulting in a net cash position that is negative after subtracting total debt. Free cash flow for the period was ¥69.36 billion, suggesting the company is generating positive cash from operations after capital expenditures. Profitability metrics show a return on equity (ROE) of 11.76%, which is relatively strong, but the return on assets (ROA) of 0.34% is weak, indicating that the company is not efficiently utilizing its assets to generate profit. These figures should be compared to the industry's preferred metrics and cohort medians to assess relative performance. The company's revenue is not segmented by geographic region or business line in the provided data, so it is not possible to determine the geographic or segment concentration of its revenue. However, the company's exposure to different markets and products is an important factor in assessing its risk profile and growth potential. The company's growth trajectory is not explicitly detailed in the provided data, but the operating income of ¥104.96 billion and net income of ¥78.79 billion suggest a profitable operation. Analysts have provided a mean price target of ¥175.70 and a median price target of ¥170.00, with a mean recommendation of 2.80, indicating a generally neutral to slightly positive outlook. The company faces a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The risk assessment also notes that net cash is negative after subtracting total debt, which could impact the company's ability to meet short-term obligations without additional financing. Recent events and filings are not detailed in the provided data, so it is not possible to comment on specific recent developments that may have impacted the company's financial position or strategic direction.

30-day price · 8729-1.10 (-0.8%)
Low$129.30High$152.40Close$141.90As of28 May, 00:00 UTC
Profile
Company8729.T
Ticker8729.T
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. The company operates in the Life & Health Insurance industry, providing insurance products and services to individuals and businesses, generating revenue primarily through premium income and investment returns on its insurance reserves.

Classification. The company is classified under the Life & Health Insurance industry within the Insurance business sector and the Financials economic sector, with a classification confidence of 0.92.

The company maintains a capital structure with a debt-to-equity ratio of 7.29, indicating a significant reliance on debt financing relative to equity. Its liquidity position is characterized by cash and equivalents of ¥1.22 trillion, but this is offset by long-term debt of ¥4.88 trillion, resulting in a net cash position that is negative after subtracting total debt. Free cash flow for the period was ¥69.36 billion, suggesting the company is generating positive cash from operations after capital expenditures. Profitability metrics show a return on equity (ROE) of 11.76%, which is relatively strong, but the return on assets (ROA) of 0.34% is weak, indicating that the company is not efficiently utilizing its assets to generate profit. These figures should be compared to the industry's preferred metrics and cohort medians to assess relative performance. The company's revenue is not segmented by geographic region or business line in the provided data, so it is not possible to determine the geographic or segment concentration of its revenue. However, the company's exposure to different markets and products is an important factor in assessing its risk profile and growth potential. The company's growth trajectory is not explicitly detailed in the provided data, but the operating income of ¥104.96 billion and net income of ¥78.79 billion suggest a profitable operation. Analysts have provided a mean price target of ¥175.70 and a median price target of ¥170.00, with a mean recommendation of 2.80, indicating a generally neutral to slightly positive outlook. The company faces a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The risk assessment also notes that net cash is negative after subtracting total debt, which could impact the company's ability to meet short-term obligations without additional financing. Recent events and filings are not detailed in the provided data, so it is not possible to comment on specific recent developments that may have impacted the company's financial position or strategic direction.
Key takeaways
  • The company has a strong ROE of 11.76%, but a weak ROA of 0.34%, indicating inefficiency in asset utilization.
  • The company's liquidity position is medium risk, with a negative net cash position after subtracting total debt.
  • Analysts have a generally neutral to slightly positive outlook, with a mean price target of ¥175.70 and a median price target of ¥170.00.
  • The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 7.29.
  • The company's growth trajectory and segment-specific performance are not detailed in the provided data.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue
Gross profit
Operating income$104.96B
Net income$78.79B
R&D
SG&A
D&A
SBC
Operating cash flow$1.50T
CapEx-$26.44B
Free cash flow$69.36B
Total assets$23.37T
Total liabilities$22.70T
Total equity$669.75B
Cash & equivalents$1.22T
Long-term debt$4.88T
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$669.75B
Net cash-$3.66T
Current ratio
Debt/Equity7.3
ROA0.3%
ROE11.8%
Cash conversion19.1%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
Metric8729Activity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity729.0%27.5% medp25 4.7% · p75 66.5%top quartile
Observations
IR observations
Mean price target175.70 JPY
Median price target170.00 JPY
High price target210.00 JPY
Low price target150.00 JPY
Mean recommendation2.80 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count8.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate10.32 JPY
Mean revenue estimate1,253,417,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 18:33 UTC#2fe8e9c9
Market quoteclose JPY 141.50 · shares 6.71B diluted
no public URL
2026-05-06 18:33 UTC#16a27785
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 04:29 UTCJob: 148e2de0